- U.S. Stock Market Movement: Oracle Plummets on September 24 Due to Sluggish AI Loan Sales, Debt Concerns, High Capital Expenditures, and Tech Stock Pullback
- BUZZ—Limited progress in US-Iran negotiations, US energy stocks rise
- Qualcomm (QCOM.US) and Apple (AAPL.US) renew global licensing agreement, effective from April 2027
- Qualcomm (QCOM.US) and Apple (AAPL.US) renew global licensing agreement effective from April 2027
- BUZZ - Versant Media shares rise; Citi initiates coverage with a “Buy” rating
- VirExit Technologies rebrands as Lavish Enterprises
- Liberty Defense grants 43,888 RSUs to directors, officers
- Fifth Third Bancorp to redeem USD 500 million senior notes on Nov. 1, 2026
- Canada July retail sales fall 0.7%; seen up 1.3% in August
- Canada August factory sales most likely up 1.1% - Statscan flash estimate
- --US Initial Jobless Claims 197,000 Vs. Expected 200,000, Prior 198,000
- Blackstone Launches BXPM for Broad Private-Markets Exposure
- Why Did SpaceX Stock Fall 4% Days Before Starship's Biggest Flight?
- --BofA Securities Initiates Coverage on MGE Energy With Neutral Rating, $76 Price Target
- Updated Version 2 - Qualcomm and Apple Reach Agreement to Extend Global Chip Licensing Deal
- HCW Biologics prices USD 1.5 million private placement at USD 1.6599 per unit
- DYNATRACE, INC. <DT.N>: OPPENHEIMER RAISES TARGET PRICE TO $71 FROM $60
- KNIFE RIVER CORPORATION <KNF.N>: OPPENHEIMER CUTS TARGET PRICE TO $80 FROM $90
- OKTA, INC. <OKTA.O>: OPPENHEIMER RAISES TARGET PRICE TO $227 FROM $190
- Everpure Continues to 'Outdo Itself.' This Analyst Says Stock Price Could Double. -- Barrons.com
- BPCE L’Observatoire sees France business failures rising to 71,000 in 2026
- Nigeria’s estimated daily average export volume of four major crude oils in November is 874,000 barrels
- Worldwide Healthcare Trust estimated NAV at 407.67p per share as of Sept. 23 close (cum income)
- Digital Brands Group targets 5x ROAS as AVO revamps e-commerce platform in October
- Digital Brands Group says AVO revenue rises 221% in Aug. 1-Sept. 11 period
- Lake Victoria Gold identifies attrition scrubbing, desliming route for Imwelo ore, lifts 24-hour gold extraction to 84.54%
- Absci Expects to Initiate Mid-Stage Trial of ABS-201 for Endometriosis in Mid-2027
- Deutz supervisory board member Dr. Dietmar Voggenreiter buys shares worth EUR 55,900
- Beneficient stock surges 439% on $130M debt fix, but trend stays unconfirmed
- Ondo crypto sits at make-or-break $0.42 pivot amid market’s 6.41% drop
- Scottie Resources to Raise Up to CA$10 Million From a Brokered Private Placement
- DarkPulse files auditor letter backing 8-K disclosures on Boladale Lawal dismissal
- ELICIO THERAPEUTICS INC <ELTX.O>: B. RILEY CUTS TARGET PRICE TO $8 FROM $27
- Bullish on Muse's monetization path, JPMorgan significantly raises Meta's target price
- Russia launches commercial crude oil exports of the "Eastern Oil" project, with initial scale far below target
- EVERPURE, INC. : MORGAN STANLEY RAISES TARGET PRICE TO $137.00 FROM $119.00
- MTU Aero Engines says United takes first Airbus A321XLR with GTF Advantage engines
- 10-Yr Benchmark Govt Yields - Germany vs Other Nations
- 10-Yr Benchmark Govt Yields - U.S. vs Other Nations
- 2-Yr Benchmark Govt Yields - Germany vs Other Nations
- 2-Yr Benchmark Govt Yields - U.S. vs Other Nations
- Canada's Jobs Market Enters Trade Downturn From Firmer Ground, CIBC Says
- Morgan Stanley Adjusts Price Target on Cinemark Holdings to $40 From $42, Keeps Overweight Rating
- Starbucks to Close About 250 Stores, Take $300 Million in Restructuring Charges
- Charles River Labs Sees FY26 Organic Rev Growth at Upper End of 0%-1% Range >CRL
- OceanaGold Provides Drill Results from Wharekirauponga Project in New Zealand
- --GUIDANCE: (CRL) Charles River Laboratories Expects 2026 Adjusted EPS at Upper End of $11.15 - $11.45, vs. FactSet Est of $11.33
- BUZZ - Delek US stock falls after announcing a $400 million convertible bond issuance plan
- Qualcomm and Apple renew global licensing agreement to take effect in April 2027
- Charles River Labs Sees FY26 Adj EPS at Upper End of $11.15-$11.45 Range >CRL
- Imunon highlights 14.7-month overall survival gain in Phase 2 IMNN-001 ovarian cancer study as Phase 3 trial advances
- Aptevo targets IND-enabling studies for trispecific cancer drug APVO451 in 1H 2027
- Rising Treasury Yields, Oil Prices Drag Down US Equity Futures Pre-Bell
- Charles River Labs Targets 2027-2030 Organic Revenue Growth of 5%-7%>CRL
- Viking Therapeutics Prices Upsized $500 Million Stock, Convertible Notes Offering
- SLB wins four multi-year Aramco well construction contracts in Saudi Arabia
- Maverick Gold and Silver begins 1,300-meter drill program at Silver Vista in British Columbia
- Collective Metals appoints Curtis Riou to board of directors
- Lowe’s partners with Wing, DoorDash for drone delivery pilot in North Carolina
- NSJ Gold Begins a 3,000-Meter Drilling Program on Antimony 2.0 Property, New Brunswick
- Annexon presents Phase 3 ARCHER II baseline data for vonaprument geographic atrophy trial at Retina Society meeting
- Magna Terra Minerals acquires 100% of three Santa Cruz gold-silver projects for US$25,000 and 1,250,000 shares
- Ethereum’s next move: Can ETH reclaim $2,700 after a $111M whale exit?
- Trident Digital Tech regains Nasdaq compliance after MVLS tops USD 35 million for 10 straight sessions
- SkyAI holds annual shareholder meeting
- 10-year U.S. Treasury yields break 5.1%: When will the U.S. Treasury TGA start buybacks?
- Garg Group seeks to oust five Better Home & Finance directors in consent fight
- Go Metals says KM98 stripping exposes 100-meter massive oxide zone; assays pending
- Netlist says US ITC opens Micron import probe over four patents
- Upbound Group declares Q4 2026 cash dividend of $0.39 a share
- KB Home opens Brighton new-home community in Hockley, Texas, priced from low $200,000s
- Charles River Expects Bioanalysis Rev to Grow Organically at High-Single-Digit CAGR to About $450 M in 2030 >CRL
- Charles River Will Expand Use of AI-assisted Digital Tools to Improve Oper Efficiency, Reduce Drug Development Timelines >CRL
- Elicio says Phase 2 AMPLIFY-7P pancreatic cancer data for ELI-002 7P earns late-breaking oral slot at ESMO 2026
- Charles River Expects Over $300 M in Cumulative Savings From 2027 Through 2030 by Simplifying Processes and Increasing Automation >CRL
- Charles River Backs 2026 Guidance With Rev, Adj EPS Expected at Upper Ends of Prior Ranges >CRL
- Updated Version 2 - Olive Garden's parent company delivers slightly lower-than-expected results as consumers continue to face pressure
- BUZZ - Piper Sandler initiates coverage on Ares and Carlyle with "Overweight" rating
- The 8th China-OPEC High-Level Dialogue was held in Beijing, reaching broad consensus.
- BUZZ - aTyr shares rise as FDA reaches agreement on advanced lung disease research program
- This Company's Software Manages Supply Chains for Retailers. Its Stock Can Surge 30%. -- Barrons.com
- Ainos signs VELDONA license deal with BioPhoenix worth up to $10 million
- Tvardi publishes new preclinical ulcerative colitis data for STAT3 inhibitor TTI-101 in Int J Mol Sci
- Cardiff Lexington signs LOI to buy multi-state musculoskeletal healthcare platform for up to $104 million
- Altcoin RENDER Breaks Out of Critical Resistance Level Only to Face Another, Will the Asset Pump Further?
- Nine Mile Metals drills 5.09% Cu-Eq over 14.15 m at Wedge Mine, New Brunswick
- Horizon Aircraft schedules fiscal Q1 2027 results webcast and business update
- Archer Announces Expiration Of Hart-Scott-Rodino Waiting Period For Its Acquisition Of Boeing's Wisk Aero, Insitu And SkyGrid Subsidiaries >ACHR
- Stock3 names Smartbroker+ as first white-label partner for stock3 Terminal
- Delek US Plans $400 Million Convertible Senior Notes Offering
- X-Energy Unit Completes Vertical Construction of TX-1 Nuclear Fuel Facility in Tennessee
- SimilarWeb CEO Or Offer disposes of USD 529,934.14 in common shares
- US Treasury yields surge hits emerging Asia! Bond spreads approach record lows, raising capital outflow risks
- AbbVie Says Health Canada Issues Notice of Compliance for EPKINLY in Follicular Lymphoma
- PEOPLE INCORPORATED : STONEX CUTS TARGET PRICE TO $63 FROM $70
- --Conagra Brands Keeps Quarterly Dividend of $0.175 a Share, Payable Dec. 3 to Holder of Record as of Nov. 5
- Qualcomm Renews Patent License Deal With Apple
- --John Wiley & Sons Keeps Quarterly Dividend at $0.3575 a Share, Payable Oct. 22 to Shareholders of Record as of Oct. 6
- Libra Energy Materials Raises CA$1.9 Million in Total After Closing Final Tranche of Offering
- Newton Golf issues 232,202 shares in unregistered warrant exchange deal
